Galapagos NV
GLPG
$29.45
Share price
1.31%
Change (1 day)
-23.94%
Change (1 year)
Categories
Galapagos NV (GLPG) - P/B ratio
P/B ratio as of April 2024 : 0.7007
According to Galapagos NV's latest financial reports the company has a price-to-book ratio of 0.7007.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Galapagos NV - P/B ratio (from 2008 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.9671 | -10.45% |
| 2022-12-31 | 1.08 | -11.5% |
| 2021-12-31 | 1.22 | -38.1% |
| 2020-12-31 | 1.97 | -52.99% |
| 2019-12-31 | 4.19 | 16.07% |
| 2018-12-31 | 3.61 | -8.6% |
| 2017-12-31 | 3.95 | 5.95% |
| 2016-12-31 | 3.73 | -39.59% |
| 2015-12-31 | 6.18 | 171.33% |
| 2014-12-31 | 2.28 | -16.16% |
| 2013-12-31 | 2.72 | -24.72% |
| 2012-12-31 | 3.61 | 55.14% |
| 2011-12-31 | 2.32 | 7.95% |
| 2010-12-31 | 2.15 | 31.8% |
| 2009-12-31 | 1.63 | 87.45% |
| 2008-12-31 | 0.8717 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.24 | 647.92% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.81 | 586.23% | 🇺🇸 USA |
 AbbVie ABBV | 28.9 | 4,020.82% | 🇺🇸 USA |
 Sanofi SNY | 1.45 | 106.70% | 🇫🇷 France |
 Merck MRK | 8.54 | 1,118.79% | 🇺🇸 USA |
 AstraZeneca AZN | 5.61 | 700.46% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 5.17 | 638.27% | 🇬🇧 UK |
 Fortress Biotech
FBIO | -2.63 | -475.20% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1.81 | 158.81% | 🇮🇱 Israel |